Virtual Symposium: Building bridges in neurodegeneration research: CRISPR, stem cells, and single-cell profiling

Exchange ideas and spark new collaborations

Buildingbr

Emerging technologies offer unprecedented opportunities to better understand the cell types and mechanisms that contribute to neurodegeneration. This virtual symposium aims to bring together groups working in different networks and institutions to exchange ideas and spark new collaborations.

Speakers:

  • Caleb Webber (UK DRI at Cardiff)
  • Carlo Sala Frigerio (UK DRI at UCL)
  • Dan Gaffney (Wellcome Sanger Institute/ Open Targets)
  • Emmanouil Metzakopian (UK DRI at Cambridge)
  • Martin Kampmann (University California, San Francisco/ Chan Zuckerberg Biohub)
  • Rick Livesey (UCL/ Open Targets)


Thursday 4 June, 14:00 - 17:00 BST

This event is open to researchers and staff across the three partnering networks: UK DRI, Open Targets, and CZI Neurodegeneration Challenge Network. Registration and associated Zoom links will be distributed via Centre Manager emails nearer the time of the event.

Founding funders

Latest tweets from @UKDRI

RT @dr_menzies: Are you interested in a PhD in small molecule anti-compliment drug development? How about this one with Dr Zelek, Prof Morg…
23 May 2022 20:39

#ICYMI: Researchers led by Prof @isaacs_adrian (UK DRI at UCL) have developed a biomarker to track the success of t… https://t.co/ir92qxqfWE
23 May 2022 16:03